See How Ebola Drugs Grow In Tobacco Leaves

TIME

It would be an understatement to call ZMapp a “sought after” drug. Ever since it brough tback two Ebola-infected aid workers from the brink of death, demand for the drug—which has not been approved by the Food and Drug Administration and was made available on an emergency use basis—has boomed. The trouble is, there’s no supply.

The doses administered to the U.S. aid workers exhausted a nearly nonexistent supply, according to its manufacturer, Mapp Biopharmaceuticals. But that’s not because it takes a long time to manufacture the antibodies that make up the ZMapp cocktail. ZMapp is taking longer to produce in large quantities because one of the three antibodies in the cocktail doesn’t grow well in the plants—which is how ZMapp is produced.

The process involves growing tobacco plants, not in the acres of fields earmarked by tobacco companies for their cigarettes, but in a controlled environment in a…

View original post 283 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s